Close Menu
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
Facebook X (Twitter) Instagram
Facebook LinkedIn
Financial Market News
Subscribe Now
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
Financial Market News
You are at:Home»Posts Tagged "weight"

Restaurants add protein, fiber for weight loss drug users

By FinMar NewsMarch 23, 2026

A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to a regular-sized combo on Dec. 8, 2025 in…

Eli Lilly obesity pill maintains weight loss after Wegovy, Zepbound 

By FinMar NewsDecember 18, 2025

The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024.Ore Huiying | Bloomberg | Getty…

What’s next for the weight loss drug market: pills, rivals, insurance

By FinMar NewsNovember 2, 2025

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | ReutersThe…

FDA approves Signos glucose monitoring for weight loss

By FinMar NewsAugust 20, 2025

Woman with Signos wearable and appSource: SignosThe Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup…

Investors pour billions into S&P equal weight fund as tech fears rise

By FinMar NewsJanuary 15, 2025

Stay informed with free updatesSimply sign up to the US equities myFT Digest — delivered directly to your inbox.Investors have poured record amounts of money into…

FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea

By FinMar NewsDecember 21, 2024

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Shelby Knowles | Bloomberg |…

GLP-1 weight loss boom spurs protein sales, Vitamin Shoppe says

By FinMar NewsJune 11, 2024

The weight loss boom is pushing consumers to spend more on protein supplement products.That’s according to new data from The Vitamin Shoppe’s 2024 Health & Wellness…

Weight loss drug ETF bets big on Eli Lilly, Novo Nordisk

By FinMar NewsMay 27, 2024

A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs.Roundhill Investments’ GLP-1 & Weight Loss ETF (OZEM), which began trading…

Amgen soars on weight loss drug progress, Novo Nordisk, Eli Lilly slide

By FinMar NewsMay 3, 2024

Amgen’s stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss injection. That fueled investor concerns about new…

Weight loss drug patients spend less on restaurants, takeout: survey

By FinMar NewsApril 20, 2024

A food delivery messenger carries a take out bag outside aSweetgreen in Manhattan on September 14, 2023.Jeenah Moon | The Washington Post | Getty ImagesA highly…

1 2 Next
Energy News

Texas leads nation in solar power installation, report finds – Houston

The economy has Strait of Hormuz deadline for Trump: Two weeks

Amid energy market turmoil, the people taking power into their own hands

Costco turns pain at the gas pump into a powerful in-store traffic driver

Banks News

Down 12% This Year, Nubank Plans a ‘100b Pivot’ And Investors Are Taking

JPMorgan Chase Stock Faces Headwinds Ahead of Earnings

Rumors emerge of a CLARITY Act deal between White House and lawmakers —

Trump’s crypto advisor confirms ‘agreement in principle’ on CLARITY Act

Real Estate News

License EDU Launches Real Estate Continuing Education Courses in Texas

UNL Releases Preliminary Farm Real Estate Market Survey Results for

‘Do they even look at them before posting?’

These Major League players spent millions on homes in metro Phoenix

© 2026 finmar.news

Type above and press Enter to search. Press Esc to cancel.